Literature DB >> 5541307

Effect of ovine prolactin administration on glucose metabolism and plasma insulin levels in the dog.

I Rathgeb, B Winkler, R Steele, N Altszuler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5541307     DOI: 10.1210/endo-88-3-718

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  7 in total

1.  [The effect of chronic prolactin administration upon the blood sugar, insulin and free fatty acid response to a glucose load in the dog].

Authors:  A Renauld; R C Sverdlik; L L Andrade
Journal:  Acta Diabetol Lat       Date:  1973

2.  In vivo insulin antagonism but evanescent in vitro tissue effect in rats with growth hormone-secreting tumors.

Authors:  M B Davidson; D C Shen; N Venkatesan; G Sladen
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

3.  Plasma prolactin in juvenile diabetics. 24-h studies with somatostatin.

Authors:  K F Hanssen; S E Christensen; A P Hansen; K Lundbaek; P A Torjesen; J Weeke
Journal:  Diabetologia       Date:  1978-11       Impact factor: 10.122

4.  Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo.

Authors:  G Schernthaner; R Prager; C Punzengruber; A Luger
Journal:  Diabetologia       Date:  1985-03       Impact factor: 10.122

5.  Hepatocyte insulin binding and action in rats with somatomammotrophic tumours.

Authors:  M B Davidson; S Melmed
Journal:  Diabetologia       Date:  1983-07       Impact factor: 10.122

6.  Prolactin: a diabetogenic hormone.

Authors:  R Landgraf; M M Landraf-Leurs; A Weissmann; R Hörl; K von Werder; P C Scriba
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

7.  Direct relationship between elevated free testosterone and insulin resistance in hyperprolactinemic women.

Authors:  S Y Kim; Y A Sung; K S Ko; B Y Cho; H K Lee; C S Koh; H K Min
Journal:  Korean J Intern Med       Date:  1993-01       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.